{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T16:00:32Z","timestamp":1773331232183,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Biol Endocrinol"],"DOI":"10.1186\/s12958-025-01434-8","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T05:34:01Z","timestamp":1751866441000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Polycystic ovary syndrome and excessive body weight impact independently and synergically on fertility treatment outcomes"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2967-2666","authenticated-orcid":false,"given":"Em\u00eddio","family":"Vale-Fernandes","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5558-8337","authenticated-orcid":false,"given":"Mafalda V.","family":"Moreira","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1941-6634","authenticated-orcid":false,"given":"Raquel L.","family":"Bernardino","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8170-9941","authenticated-orcid":false,"given":"Daniela","family":"Sousa","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8030-0702","authenticated-orcid":false,"given":"Raquel","family":"Brand\u00e3o","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6881-724X","authenticated-orcid":false,"given":"Carla","family":"Leal","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8849-0862","authenticated-orcid":false,"given":"M\u00e1rcia","family":"Barreiro","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0662-1831","authenticated-orcid":false,"given":"Mariana P.","family":"Monteiro","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,7,7]]},"reference":[{"key":"1434_CR1","doi-asserted-by":"crossref","unstructured":"Singh S et al. Polycystic ovary syndrome: etiology, current management, and future therapeutics. J Clin Med, 2023. 12(4).","DOI":"10.3390\/jcm12041454"},{"issue":"1","key":"1434_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/GRF.0000000000000563","volume":"64","author":"JA Lentscher","year":"2021","unstructured":"Lentscher JA, Decherney AH. Clinical presentation and diagnosis of polycystic ovarian syndrome. Clin Obstet Gynecol. 2021;64(1):3\u201311.","journal-title":"Clin Obstet Gynecol"},{"issue":"1","key":"1434_CR3","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1186\/s12905-022-02036-x","volume":"22","author":"VC Dornelles","year":"2022","unstructured":"Dornelles VC, et al. The impact of body mass index on laboratory, clinical outcomes and treatment costs in assisted reproduction: a retrospective cohort study. BMC Womens Health. 2022;22(1):479.","journal-title":"BMC Womens Health"},{"issue":"2","key":"1434_CR4","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1089\/obe.2007.0019","volume":"3","author":"S Sam","year":"2007","unstructured":"Sam S. Obesity and polycystic ovary syndrome. Obes Manag. 2007;3(2):69\u201373.","journal-title":"Obes Manag"},{"issue":"6","key":"1434_CR5","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1093\/humupd\/dms030","volume":"18","author":"SS Lim","year":"2012","unstructured":"Lim SS, et al. Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2012;18(6):618\u201337.","journal-title":"Hum Reprod Update"},{"key":"1434_CR6","doi-asserted-by":"publisher","first-page":"117955811987404","DOI":"10.1177\/1179558119874042","volume":"13","author":"TM Barber","year":"2019","unstructured":"Barber TM, et al. Obesity and polycystic ovary syndrome: implications for pathogenesis and novel management strategies. Clin Med Insights Reprod Health. 2019;13:1179558119874042.","journal-title":"Clin Med Insights Reprod Health"},{"issue":"1","key":"1434_CR7","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s12905-024-03028-9","volume":"24","author":"BV Boldis","year":"2024","unstructured":"Boldis BV, et al. Comorbidities in women with polycystic ovary syndrome: a sibling study. BMC Womens Health. 2024;24(1):221.","journal-title":"BMC Womens Health"},{"issue":"4","key":"1434_CR8","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/cen.14421","volume":"95","author":"TM Barber","year":"2021","unstructured":"Barber TM, Franks S. Obesity and polycystic ovary syndrome. Clin Endocrinol (Oxf). 2021;95(4):531\u201341.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"1434_CR9","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12958-023-01120-7","volume":"21","author":"AM Kotlyar","year":"2023","unstructured":"Kotlyar AM, Seifer DB. Women with PCOS who undergo IVF: a comprehensive review of therapeutic strategies for successful outcomes. Reprod Biol Endocrinol. 2023;21(1):70.","journal-title":"Reprod Biol Endocrinol"},{"key":"1434_CR10","doi-asserted-by":"crossref","unstructured":"Hynes JS, et al. Body mass index is negatively associated with a good perinatal outcome after in vitro fertilization among patients with polycystic ovary syndrome: a National study. Volume 4. F S Rep; 2023. pp. 77\u201384. 1.","DOI":"10.1016\/j.xfre.2022.11.014"},{"issue":"2","key":"1434_CR11","doi-asserted-by":"publisher","first-page":"e1631","DOI":"10.1016\/j.ajog.2014.03.035","volume":"211","author":"AP Bailey","year":"2014","unstructured":"Bailey AP, et al. Effect of body mass index on in vitro fertilization outcomes in women with polycystic ovary syndrome. Am J Obstet Gynecol. 2014;211(2):e1631\u20136.","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"1434_CR12","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.rbmo.2020.11.013","volume":"42","author":"M Bourdon","year":"2021","unstructured":"Bourdon M, et al. The freeze-all strategy after IVF: which indications? Reprod Biomed Online. 2021;42(3):529\u201345.","journal-title":"Reprod Biomed Online"},{"key":"1434_CR13","doi-asserted-by":"crossref","unstructured":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod, 2004. 19(1): pp. 41\u2013\u20097.","DOI":"10.1093\/humrep\/deh098"},{"issue":"9","key":"1434_CR14","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1093\/humrep\/deu139","volume":"29","author":"AP Ferraretti","year":"2014","unstructured":"Ferraretti AP, Gianaroli L. The Bologna criteria for the definition of poor ovarian responders: is there a need for revision? Hum Reprod. 2014;29(9):1842\u20135.","journal-title":"Hum Reprod"},{"issue":"1","key":"1434_CR15","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.rbmo.2011.09.017","volume":"24","author":"J Pundir","year":"2012","unstructured":"Pundir J, et al. Meta-analysis of GnRH antagonist protocols: do they reduce the risk of OHSS in PCOS? Reprod Biomed Online. 2012;24(1):6\u201322.","journal-title":"Reprod Biomed Online"},{"issue":"4","key":"1434_CR16","doi-asserted-by":"publisher","first-page":"R29","DOI":"10.1093\/ejendo\/lvaf062","volume":"192","author":"E Vale-Fernandes","year":"2025","unstructured":"Vale-Fernandes E, Pignatelli D, Monteiro MP. Should anti-M\u00fcllerian hormone be a diagnosis criterion for polycystic ovary syndrome? An in-depth review of pros and cons. Eur J Endocrinol. 2025;192(4):R29\u201343.","journal-title":"Eur J Endocrinol"},{"key":"1434_CR17","doi-asserted-by":"publisher","first-page":"112536","DOI":"10.1016\/j.mce.2025.112536","volume":"602","author":"E Vale-Fernandes","year":"2025","unstructured":"Vale-Fernandes E, et al. Follicular fluid profiling unveils anti-M\u00fcllerian hormone alongside glycolytic and mitochondrial dysfunction as markers of polycystic ovary syndrome. Mol Cell Endocrinol. 2025;602:112536.","journal-title":"Mol Cell Endocrinol"},{"issue":"12","key":"1434_CR18","doi-asserted-by":"publisher","first-page":"3150","DOI":"10.3390\/biomedicines11123150","volume":"11","author":"E Vale-Fernandes","year":"2023","unstructured":"Vale-Fernandes E, et al. Elevated Anti-Mullerian hormone as a prognostic factor for poor outcomes of in vitro fertilization in women with polycystic ovary syndrome. Biomedicines. 2023;11(12):3150.","journal-title":"Biomedicines"},{"key":"1434_CR19","doi-asserted-by":"publisher","first-page":"1408879","DOI":"10.3389\/fcell.2024.1408879","volume":"12","author":"E Vale-Fernandes","year":"2024","unstructured":"Vale-Fernandes E, et al. Anti-Mullerian hormone a surrogate of follicular fluid oxidative stress in polycystic ovary syndrome? Front Cell Dev Biol. 2024;12:1408879.","journal-title":"Front Cell Dev Biol"},{"issue":"7","key":"1434_CR20","first-page":"2248","volume":"82","author":"AE Taylor","year":"1997","unstructured":"Taylor AE, et al. Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. J Clin Endocrinol Metab. 1997;82(7):2248\u201356.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1434_CR21","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1210\/endrev\/bnad027","volume":"45","author":"PC Eng","year":"2024","unstructured":"Eng PC, et al. Obesity-Related hypogonadism in women. Endocr Rev. 2024;45(2):171\u201389.","journal-title":"Endocr Rev"},{"key":"1434_CR22","doi-asserted-by":"publisher","first-page":"151","DOI":"10.2147\/IJWH.S393594","volume":"15","author":"H Zhao","year":"2023","unstructured":"Zhao H, et al. The relationship between insulin resistance and obesity and serum Anti-Mullerian hormone level in Chinese women with polycystic ovary syndrome: A retrospective, Single-Center cohort study. Int J Womens Health. 2023;15:151\u201366.","journal-title":"Int J Womens Health"},{"issue":"4","key":"1434_CR23","first-page":"597","volume":"28","author":"AB Reis","year":"2024","unstructured":"Reis AB, et al. Anti-Mullerian hormone as a predictor of the number of oocytes obtained during in vitro fertilization treatments. JBRA Assist Reprod. 2024;28(4):597\u2013603.","journal-title":"JBRA Assist Reprod"},{"issue":"2","key":"1434_CR24","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/MED.0b013e3283514e13","volume":"19","author":"OT Hardy","year":"2012","unstructured":"Hardy OT, Czech MP, Corvera S. What causes the insulin resistance underlying obesity? Curr Opin Endocrinol Diabetes Obes. 2012;19(2):81\u20137.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"1434_CR25","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-Alarc\u00f3n M et al. Obesity and hyperandrogenemia in polycystic ovary syndrome: clinical implications. J Pers Med, 2023. 13(9).","DOI":"10.3390\/jpm13091319"},{"key":"1434_CR26","doi-asserted-by":"publisher","first-page":"100937","DOI":"10.1016\/j.molmet.2020.01.001","volume":"35","author":"MA Sanchez-Garrido","year":"2020","unstructured":"Sanchez-Garrido MA, Tena-Sempere M. Metabolic dysfunction in polycystic ovary syndrome: pathogenic role of androgen excess and potential therapeutic strategies. Mol Metab. 2020;35:100937.","journal-title":"Mol Metab"},{"key":"1434_CR27","doi-asserted-by":"publisher","first-page":"741764","DOI":"10.3389\/fendo.2021.741764","volume":"12","author":"H Ding","year":"2021","unstructured":"Ding H, et al. Resistance to the insulin and elevated level of androgen: A major cause of polycystic ovary syndrome. Front Endocrinol (Lausanne). 2021;12:741764.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1434_CR28","doi-asserted-by":"publisher","first-page":"204201882093431","DOI":"10.1177\/2042018820934319","volume":"11","author":"P Kempegowda","year":"2020","unstructured":"Kempegowda P, et al. Implicating androgen excess in propagating metabolic disease in polycystic ovary syndrome. Ther Adv Endocrinol Metab. 2020;11:2042018820934319.","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"2","key":"1434_CR29","doi-asserted-by":"publisher","first-page":"e3599","DOI":"10.1002\/dmrr.3599","volume":"39","author":"S Mustaniemi","year":"2023","unstructured":"Mustaniemi S, et al. Associations of low sex hormone-binding Globulin and androgen excess in early pregnancy with fasting and post-prandial hyperglycaemia, gestational diabetes, and its severity. Diabetes Metab Res Rev. 2023;39(2):e3599.","journal-title":"Diabetes Metab Res Rev"},{"issue":"2","key":"1434_CR30","doi-asserted-by":"publisher","first-page":"bvad169","DOI":"10.1210\/jendso\/bvad169","volume":"8","author":"A Chen-Patterson","year":"2024","unstructured":"Chen-Patterson A, et al. Distinct reproductive phenotypes segregate with differences in body weight in adolescent polycystic ovary syndrome. J Endocr Soc. 2024;8(2):bvad169.","journal-title":"J Endocr Soc"},{"key":"1434_CR31","doi-asserted-by":"crossref","unstructured":"Si M et al. Metabolic syndrome rather than other phenotypes in PCOS as a predictive Indicator for clinical outcomes in IVF: comprehensive phenotypic assessment across all PCOS classifications. J Clin Med, 2023. 12(15).","DOI":"10.3390\/jcm12155073"},{"issue":"5","key":"1434_CR32","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.2337\/dc13-1965","volume":"37","author":"MM Hedderson","year":"2014","unstructured":"Hedderson MM, et al. Prepregnancy SHBG concentrations and risk for subsequently developing gestational diabetes mellitus. Diabetes Care. 2014;37(5):1296\u2013303.","journal-title":"Diabetes Care"},{"key":"1434_CR33","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.diabres.2019.04.028","volume":"152","author":"S Faal","year":"2019","unstructured":"Faal S, et al. Sex hormone binding Globulin for prediction of gestational diabetes mellitus in pre-conception and pregnancy: A systematic review. Diabetes Res Clin Pract. 2019;152:39\u201352.","journal-title":"Diabetes Res Clin Pract"},{"key":"1434_CR34","doi-asserted-by":"publisher","first-page":"1130211","DOI":"10.3389\/fendo.2023.1130211","volume":"14","author":"J Huang","year":"2023","unstructured":"Huang J, et al. The effect of peak serum estradiol level during ovarian stimulation on cumulative live birth and obstetric outcomes in freeze-all cycles. Front Endocrinol (Lausanne). 2023;14:1130211.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1434_CR35","doi-asserted-by":"publisher","first-page":"615957","DOI":"10.3389\/fendo.2020.615957","volume":"11","author":"B Sun","year":"2020","unstructured":"Sun B, et al. Factors associated with ovarian hyperstimulation syndrome (OHSS) severity in women with polycystic ovary syndrome undergoing IVF\/ICSI. Front Endocrinol (Lausanne). 2020;11:615957.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"1434_CR36","first-page":"102","volume":"25","author":"C Jreij","year":"2024","unstructured":"Jreij C, et al. The effect of progesterone elevation on the day of trigger administration: A review of the literature. J Reprod Infertil. 2024;25(2):102\u20139.","journal-title":"J Reprod Infertil"},{"issue":"9","key":"1434_CR37","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1093\/humrep\/deab160","volume":"36","author":"A Racca","year":"2021","unstructured":"Racca A, et al. Is a freeze-all policy the optimal solution to circumvent the effect of late follicular elevated progesterone? A multicentric matched-control retrospective study analysing cumulative live birth rate in 942 non-elective freeze-all cycles. Hum Reprod. 2021;36(9):2463\u201372.","journal-title":"Hum Reprod"},{"issue":"6","key":"1434_CR38","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1056\/NEJMoa1513873","volume":"375","author":"ZJ Chen","year":"2016","unstructured":"Chen ZJ, et al. Fresh versus frozen embryos for infertility in the polycystic ovary syndrome. N Engl J Med. 2016;375(6):523\u201333.","journal-title":"N Engl J Med"},{"issue":"2","key":"1434_CR39","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.fertnstert.2017.10.020","volume":"109","author":"B Zhang","year":"2018","unstructured":"Zhang B, et al. Obstetric complications after frozen versus fresh embryo transfer in women with polycystic ovary syndrome: results from a randomized trial. Fertil Steril. 2018;109(2):324\u20139.","journal-title":"Fertil Steril"},{"issue":"6","key":"1434_CR40","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1007\/s10815-023-02804-0","volume":"40","author":"Y Fouks","year":"2023","unstructured":"Fouks Y, et al. ART outcomes in lean compared to obese phenotypes of polycystic ovarian syndrome. J Assist Reprod Genet. 2023;40(6):1437\u201345.","journal-title":"J Assist Reprod Genet"},{"issue":"3","key":"1434_CR41","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1007\/s13679-024-00580-1","volume":"13","author":"K Sweatt","year":"2024","unstructured":"Sweatt K, Garvey WT, Martins C. Strengths and limitations of BMI in the diagnosis of obesity: what is the path forward?? Curr Obes Rep. 2024;13(3):584\u201395.","journal-title":"Curr Obes Rep"},{"key":"1434_CR42","doi-asserted-by":"crossref","unstructured":"Carmina E, Lobo RA. Comparing lean and obese PCOS in different PCOS phenotypes: evidence that the body weight is more important than the Rotterdam phenotype in influencing the metabolic status. Diagnostics (Basel), 2022. 12(10).","DOI":"10.3390\/diagnostics12102313"},{"issue":"1","key":"1434_CR43","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12958-024-01339-y","volume":"23","author":"J Duah","year":"2025","unstructured":"Duah J, Seifer DB. Medical therapy to treat obesity and optimize fertility in women of reproductive age: a narrative review. Reprod Biol Endocrinol. 2025;23(1):2.","journal-title":"Reprod Biol Endocrinol"},{"key":"1434_CR44","doi-asserted-by":"crossref","unstructured":"Moreira T, et al. Predictors of pregnancy after artificial insemination in women with polycystic ovary syndrome. JBRA Assist Reprod; 2025.","DOI":"10.5935\/1518-0557.20240095"}],"container-title":["Reproductive Biology and Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-025-01434-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12958-025-01434-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-025-01434-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T05:34:04Z","timestamp":1751866444000},"score":1,"resource":{"primary":{"URL":"https:\/\/rbej.biomedcentral.com\/articles\/10.1186\/s12958-025-01434-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,7]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1434"],"URL":"https:\/\/doi.org\/10.1186\/s12958-025-01434-8","relation":{},"ISSN":["1477-7827"],"issn-type":[{"value":"1477-7827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,7]]},"assertion":[{"value":"30 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients enrolled in the study provided written informed consent to participate. This study was conducted in accordance with the principles of the Declaration of Helsinki. The study protocol was authorized by the Ethics Committee of the Unidade Local de Sa\u00fade de Santo Ant\u00f3nio (ULSSA) \/ Instituto de Ci\u00eancias Biom\u00e9dicas Abel Salazar (ICBAS) [2020.119(097-DEFI\/099-CE)].","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All authors declare no conflicts of interest. The funding institutions had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"97"}}